Respiratory tract infection due to atypical pathogens:the etiological resistance and the antimicrobial treatment.
- VernacularTitle:非典型病原体的耐药性及其所致呼吸道感染的抗菌治疗
- Author:
Yang LIU
;
Minggui WANG
- Publication Type:Journal Article
- Keywords:
atypical pathogens;
Mycoplasma pneumoniae;
Chlamydia pneumoniae;
Legionella pneumophila
- From:
Chinese Journal of Practical Internal Medicine
2002;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
Mycoplasma pneumoniae,Chlamydia pneumoniae and Legionella pneumophila are recognized as common and important pathogens in community-acquired respiratory tract infections(RTIs).Macrolides,tetracyclines and fluoroquinolones are the most commonly employed drugs in the treatment of these atypical pathogen infections.Macrolide-resistant M.pneumoniae strains have been reported in Japan,China,France and the United States since 2000.Advances in atypical pathogen infections,etiological resistance and antimicrobial treatment are reviewed in this article. Abstract:Summ ary:Mycoplasma pneum oniae,Chlamydia pneum oniaeandLegionella pneum ophilaare recogn ized as common and important pathogens in commun ity-acqu ired resp iratory tract infections(RTIs).M acrolides,tetracyc lines and fluoroqu ino-lones are the most common ly emp loyed drugs in the treatm ent of these atyp ical pathogen infections.M acrolide-resistantM.pneumon iae strains have been reported in Japan,Ch ina,France and the Un ited States since 2000.Advances in atyp ical pathogen infections,etiological resistance and antim icrob ial treatm ent are reviewed in th is artic le.